Robert J. De Vaere
2012
In 2012, Robert J. De Vaere earned a total compensation of $947.2K as Executive Vice President and Chief Financial Officer at Horizon Pharma, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,000 |
|---|---|
| Salary | $364,000 |
| Stock Awards | $462,000 |
| Other | $1,156 |
| Total | $947,156 |
De Vaere received $462K in stock awards, accounting for 49% of the total pay in 2012.
De Vaere also received $120K in non-equity incentive plan, $364K in salary and $1.2K in other compensation.
Rankings
In 2012, Robert J. De Vaere's compensation ranked 6,335th out of 11,487 executives tracked by ExecPay. In other words, De Vaere earned more than 44.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,335 out of 11,487 | 45th |
Division Manufacturing | 2,267 out of 4,253 | 47th |
Major group Chemicals And Allied Products | 570 out of 1,198 | 52nd |
Industry group Drugs | 390 out of 920 | 58th |
Industry Pharmaceutical Preparations | 306 out of 700 | 56th |
Source: SEC filing on June 2, 2014.
De Vaere's colleagues
We found four more compensation records of executives who worked with Robert J. De Vaere at Horizon Pharma in 2012.
2012
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2012
Jeffrey Sherman
Horizon Pharma
Chief Medical Officer
2012
Todd Smith
Horizon Pharma
Executive Vice President and Chief Commercial Officer
2012
Michael Adatto
Horizon Pharma